Navigation Links
Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Date:10/17/2011

hydrochloride) 43

4.2.4 Serotonin-Norepinephrine Reuptake Inhibitors (SNRI) 44

4.2.5 Cymbalta (duloxetine hydrochloride) 44

4.2.6 Pristiq (desvenlafaxine succinate) 45

4.2.7 Symbyax (olanzapine and fluoxetine combination) 46

4.3 Key Takeaway 48

5 Depression Therapeutics - Pipeline Assessment 49

5.1 Overview 49

5.2 Strategic Pipeline Assessment 49

5.3 Depression Therapeutics Pipeline – Pipeline by Phases of Development 49

5.3.1 Depression Therapeutics – Phase III Pipeline 50

5.3.2 Depression Therapeutics – Phase II Pipeline 50

5.3.3 Depression Therapeutics – Phase I Pipeline 51

5.3.4 Depression Market – Pre-Clinical Pipeline 52

5.3.5 Technology Trends Analytic Framework 52

5.4 Depression Therapeutics Market –Pipeline by Mechanism of Action 56

5.5 Depression Therapeutics – Promising Drugs under Clinical Development 57

5.6 Molecule Profile for Promising Drugs Under Clinical Development 57

5.6.1 Lu AA21004 57

5.6.2 TC-5214 58

5.6.3 AGO178 (agomelatine) 59

5.7 Key Takeaway 60

6 Depression Therapeutics - Clinical Trials Mapping 61

6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 61

6.2 Clinical Trials by Phase 62

6.3 Clinical Trials by Trial Status 63

6.4 Prominent Sponsors 64

6.5 Top Companies Participating in Depression Therapeutics Clinical Trials 66

7 Strategic Assessment 67

7.1 Key Events Impacting the Future Market 67

7.2 Depression Therapeutics: Implications for Future Market Competition 68

8 Depression Therapeutics: Future Players 69

8.1 Introduction 69

8.2 Company Profiles 69

8.2.1 Lundbeck A/S 69

8.2.2 Novartis AG 71

8.2.3 AstraZeneca PLC 72

8.2.4 Eli Lilly and Company 74

8.2.5 Targacept Inc. 75

9 Depression Therapeutics - Licensing and Partner
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Phreesias Digital Depression Screening Improves Early Detection and Drives Better Healthcare Outcomes in Medical Practices
2. Potential Mechanism of Action Identified for the Treatment of Major Depression With Trigeminal Nerve Stimulation (TNS) - The USB Port to the Brain™
3. Reportlinker Adds Product Profiles: Depression - Next generation Vies for Second-Line Patients
4. Naurex Initiates Phase II Clinical Trial of Novel Antidepressant GLYX-13 in Treatment-Resistant Depression
5. Neuralstem Updates NSI-189 Major Depression Trial
6. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
7. CeNeRx Initiates Phase II Trial of TriRima™ as Monotherapy in Treatment Resistant Depression
8. Neuralstem Receives FDA Approval to Commence Drug Trial for Major Depression
9. Omega-3 Supplements Show Promise in Alleviating Depression
10. The Welcome Back Awards Seeks Nominations to Honor Leaders in the Depression Community
11. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2015)... -- Edwards Lifesciences Corporation (NYSE: EW ), the global ... monitoring, today reported net income for the quarter ended ... share.  Net income for the same period a year ... and non-GAAP net income was $82.1 million, or $0.76 ... quarter ended March 31, 2015 increased 13.0 percent to $590.3 ...
(Date:4/23/2015)... DUBLIN , April 23, 2015  Jazz Pharmaceuticals ... will report its 2015 first quarter financial results on ... financial markets.  Company management will host a live audio ... p.m. IST to discuss first quarter 2015 financial results ... Interested parties may access the live audio webcast via ...
(Date:4/23/2015)... , April 23, 2015  DanDrit Biotech A/S ... USA , Inc. ("DanDrit"), (symbol : ... approved vaccine for the treatment of colorectal cancer, ... Pharma have signed a partnership agreement in ... collaboration agreement advances DanDrit,s goal to deliver an ...
Breaking Medicine Technology:Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16Jazz Pharmaceuticals to Report 2015 First Quarter Financial Results on May 7, 2015 2DanDrit Biotech and Riyadh Pharma Sign Partnership Agreement 2
... Corp. (Nasdaq: BSTC ; the "Company" or ... products, today announced that its Board of Directors has ... 14, 2002 and previously amended June 19, 2003 (the ... for determining "Acquiring Person" status under the Rights Agreement ...
... Feb. 7, 2011 Cancer ... served by just 11 modern radiotherapy linear accelerators, now ... Systems (NYSE: VAR). Treatments using fast and efficient RapidArc® ... Clinac® iX medical linear accelerator at the new United ...
Cached Medicine Technology:Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 2Cancer Patients in Bangladesh Gain Access to Advanced RapidArc Radiotherapy Treatments from Varian Medical Systems 3
(Date:4/25/2015)... Sports controversies continue to revolve around issues of ... the case with the Miami Dolphins and Richie Incognito, or off ... Ray Rice domestic abuse case. In a recent episode of ... the implications of locker room culture on teams. He examines what ... should do to improve the locker room as a work place. ...
(Date:4/24/2015)... 24, 2015 Multi Customer Discount , ... pumping ( http://www.zeitersseptics.com/multi-customer-discount.html ) of 1000-1500 gallons in Zeiter's ... program. This does not include any Dig fees, or ... per person. If someone is part of this group ... totaling approximately 2500 gallons or more, the cost would ...
(Date:4/24/2015)... April 24, 2015 Lipitor lawsuits ... in the federal multidistrict litigation underway in U.S. ... court documents, the parties involved in the proceeding ... detailing, among other things, preparation for the litigation’s ... for both plaintiffs and defendants have conducted depositions ...
(Date:4/24/2015)... 2015 Carinsurancequotesinfo.com has released a new ... how to qualify for auto insurance as ... for auto insurance online, without having to follow a ... single parents can reduce their auto insurance expenses. The ... properly explained. , Clients can now visit an ...
(Date:4/24/2015)... With years of experience providing ... proud to be partnered with a veterinary college where ... year. This partnership has brought new payment options for ... After providing an in-house payment plan for many years, ... wanted to increase financing options available to avoid having ...
Breaking Medicine News(10 mins):Health News:David Steele Discusses Locker Room Culture on SCI TV 2Health News:David Steele Discusses Locker Room Culture on SCI TV 3Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 2Health News:Zeiter's Septics Inc. Offers Multi Customer Septic Tank Cleaning Program in Cook, Putnam & Will Counties in May 2015 3Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 2Health News:Federal Lipitor Lawsuits Progress, as New Status Report Details Preparation for Upcoming Bellwether Trials 3Health News:Auto Insurance Discounts for Single Parents - How to Qualify for Low Rates 2Health News:University of Missouri Veterinary Medical Teaching Hospital Teams with UGA 2
... are calling for greater clarity on the legal implications of ... that this is often done following staff needlestick injuries, in ... the September issue of Anaesthesia , reports on the ... England, Wales and Northern Ireland. It is accompanied by ...
... rapidly, the University of Missouri has made a commitment to ... community and across the country. MU was one of ... Difficult Dialogues Initiative (DDI) in 2005, and one of only ... additional $100,000 grant in 2008. DDI activities focus on teaching ...
... , MONDAY, Aug. 30 (HealthDay News) -- The rate of ... steps are needed to reverse the trend, a new study ... delivery climbed by more than 50 percent, and "one in ... lead researcher Dr. Jun Zhang, of the Eunice Kennedy Shriver ...
... with acute coronary syndromes initially treated with the anticoagulant ... angioplasty) and received a lower dose of the anticoagulant ... rate of major bleeding and vascular access site complications, ... September 22 issue of JAMA . The study ...
... University, has found that lower doses of a ... did not reduce bleeding or vascular complications compared ... with a blood thinner, fondaparinux. In a ... McMaster University showed that a blood thinner fondaparinux ...
... -- The incidence of acute myocardial infarction in Italy ... 2001 and 2005, according to a comprehensive study funded ... charity for biomedical research and health education in Spoleto, ... Experimental Research . "The study suggests that more information ...
Cached Medicine News:Health News:Hospitals face legal dilemma if they test incapacitated patients after needle accidents 2Health News:Hospitals face legal dilemma if they test incapacitated patients after needle accidents 3Health News:Hospitals face legal dilemma if they test incapacitated patients after needle accidents 4Health News:Difficult Dialogues Initiative promotes diversity at MU, around country 2Health News:Almost 1 in 3 First-Time Deliveries Now Via C-Section 2Health News:Almost 1 in 3 First-Time Deliveries Now Via C-Section 3Health News:Almost 1 in 3 First-Time Deliveries Now Via C-Section 4Health News:Lower-dose heparin use during coronary procedure does not appear to reduce risk of major bleeding 2Health News:Lower-dose heparin use during coronary procedure does not appear to reduce risk of major bleeding 3Health News:Drug trial results refine treatment during angioplasty operations 2Health News:Drug trial results refine treatment during angioplasty operations 3Health News:Heart attacks jump in young Italian women 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: